ACTRN12614000171617已完成1 期
A phase 1 dose escalation study to evaluate the safety, tolerability and pharmacokinetics of DTX-SPL8783 (a docetaxel (DTX)-dendrimer conjugate) in patients with advanced solid tumours.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with histologically or cytologically confirmed advanced or metastatic cancer for which no standard or curative therapy exists; life expectancy of greater than 12 weeks;measurable or evaluable disease by RECIST.
排除标准
- •Allergy to docetaxel or other components of study therapy or compounds of similar chemical composition; uncontrolled intercurrent illness; participation in a study of an investigational agent within 30 days prior to first study therapy.
研究者
相似试验
已完成
1 期
A study to evaluate the safety, tolerability and pharmacokinetics of ACT001 in patients with advanced solid tumorsSolid tumorsCancer - Any cancerACTRN12616000228482Accendatech AU Pty Ltd36
招募中
1 期
A study to evaluate the safety,tolerability and pharmacokinetics of ACT001 in children with advanced brain and solid tumorsACTRN12618001934235Accendatech AU Pty Ltd40
招募中
1 期
A study to evaluate the safety, tolerability and pharmacokinetics of ACT001 in patients with advanced solid tumors (PART B).Glioblastoma MultiformeACTRN12621001172897Accendatech AU Pty Ltd21
尚未招募
1 期
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MRX-I Tablets in Healthy Adult Subjects (Part 3)This study is for healthy volunteers. The intended use of the investigational product is the treatment of serious gram-positive bacterial infectionsInfection - Studies of infection and infectious agentsACTRN12613001212741CPR Pharma Services24
尚未招募
1 期
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MRX-I Tablets in Healthy Adult Subjects (Part 2)This study is for healthy volunteers. The intended use of the investigational product is the treatment of serious gram-positive bacterial infectionsInfection - Studies of infection and infectious agentsACTRN12613001211752CPR Pharma Services12